SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-011914
Filing Date
2018-05-08
Accepted
2018-05-08 16:55:39
Documents
5
Period of Report
2018-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20180508.htm 8-K 39892
2 EX-1.1 xene-ex11_6.htm EX-1.1 242383
3 EX-5.1 xene-ex51_7.htm EX-5.1 11374
4 GRAPHIC g201805081952281772349.jpg GRAPHIC 3119
5 GRAPHIC g201805081952281642348.jpg GRAPHIC 15580
  Complete submission text file 0001564590-18-011914.txt   320833
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 18815480
SIC: 2834 Pharmaceutical Preparations